-
The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men.
-
A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent;
Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology
of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen
for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed
Covers in Patients with Allergic Rhinitis
-
Sarcoidosis is a multisystem granulomatous disease most often affecting the lungs, eyes, skin, and liver, with neurological involvement in 5-10%.
-
Roos and associates reviewed the effect of antifibrinolytic treatment in patients with aneurysmal subarachnoid hemorrhage.
-
Among myasthenia gravis patients who are seronegative (SNMG) for acetylcholine receptor antibodies (AchR Ab), up to 70% demonstrate positivity for IgG antimuscle-specific kinase (MuSK) antibodies. How do they differ clinically from SNMG patients negative for both AchR Ab and MuSK Ab?
-
Topiramate may soon legitimately be added to the list of Anticonvulsants useful for the control of painful diabetic peripheral neuropathy.
-
Carran and colleagues describe the development of mania and depression in patients undergoing surgery for intractable epilepsy.
-
Bond et al have shown by metaanalysis that the classification of ischemic events into different categories such as ocular TIA, cerebral TIA, and cerebral infarction leads to differences in surgical operative risk and benefit.
-
The most recent publication of the deCODE investigators from Iceland describes the steps they took to go from a linked chromosomal region to culprit gene.
-
Buljevac and colleagues assessed whether life events that are perceived as stressful by patients themselves are associated with exacerbations.
